AtriCure, Inc. Payments to Acquire Available-for-sale Securities
AtriCure, Inc. (ATRC) reported Payments to Acquire Available-for-sale Securities of $94.82 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2021-08-05
- AtriCure, Inc. payments to acquire available-for-sale securities for the quarter ending 2020-12-31 was $26.25M, a 302.42% increase year-over-year.
- AtriCure, Inc. payments to acquire available-for-sale securities for the quarter ending 2020-09-30 was $73.73M, a 110.05% increase year-over-year.
- AtriCure, Inc. payments to acquire available-for-sale securities for the quarter ending 2019-12-31 was $6.52M, a 91.48% decline year-over-year.
- AtriCure, Inc. payments to acquire available-for-sale securities for the quarter ending 2019-09-30 was $35.10M, a 441.23% increase year-over-year.
- AtriCure, Inc. payments to acquire available-for-sale securities for fiscal 2020 was $227.04M, a 209.96% increase from fiscal 2019.
- AtriCure, Inc. payments to acquire available-for-sale securities for fiscal 2019 was $73.25M, a 31.28% decline from fiscal 2018.
- AtriCure, Inc. payments to acquire available-for-sale securities for fiscal 2018 was $106.59M, a 547.75% increase from fiscal 2017.
- AtriCure, Inc. payments to acquire available-for-sale securities for fiscal 2017 was $16.45M, a 42.45% decline from fiscal 2016.
| Period end | Payments to Acquire Available-for-sale Securities 3 month | Payments to Acquire Available-for-sale Securities 3 month as first filed | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 6 month as first filed | Payments to Acquire Available-for-sale Securities 9 month | Payments to Acquire Available-for-sale Securities 9 month as first filed | Payments to Acquire Available-for-sale Securities 12 month | Payments to Acquire Available-for-sale Securities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | $94.82M 10-Q · filed 2021-08-05 | |||||||
| 2020-12-31 | $26.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $99.98M derived: sum of 2 quarters · filed 2021-02-26 | $227.04M 10-K · filed 2021-02-26 | |||||
| 2020-09-30 | $73.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $200.79M 10-Q · filed 2020-11-06 | ||||||
| 2020-06-30 | $127.07M 10-Q · filed 2021-08-05 | |||||||
| 2019-12-31 | $6.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $41.62M derived: sum of 2 quarters · filed 2021-02-26 | $70.30M derived: sum of 3 quarters · filed 2021-02-26 | $73.25M 10-K · filed 2021-02-26 | ||||
| 2019-09-30 | $35.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $63.78M derived: sum of 2 quarters · filed 2020-11-06 | $66.73M 10-Q · filed 2020-11-06 | $143.32M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $28.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $31.63M 10-Q · filed 2020-07-29 | $108.22M derived: sum of 3 quarters · filed 2021-02-26 | $114.70M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $2.95M 10-Q · filed 2020-04-30 | $79.54M derived: sum of 2 quarters · filed 2021-02-26 | $86.03M derived: sum of 3 quarters · filed 2021-02-26 | $99.18M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $76.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $83.08M derived: sum of 2 quarters · filed 2021-02-26 | $96.23M derived: sum of 3 quarters · filed 2021-02-26 | $106.59M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $6.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $19.64M derived: sum of 2 quarters · filed 2019-10-31 | $30.00M 10-Q · filed 2019-10-31 | $33.68M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $13.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $23.51M 10-Q · filed 2019-07-31 | $27.20M derived: sum of 3 quarters · filed 2020-02-24 | $32.40M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $10.36M 10-Q · filed 2019-04-26 | $14.04M derived: sum of 2 quarters · filed 2020-02-24 | $19.25M derived: sum of 3 quarters · filed 2020-02-24 | $23.72M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $3.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $8.89M derived: sum of 2 quarters · filed 2020-02-24 | $13.36M derived: sum of 3 quarters · filed 2020-02-24 | $16.45M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $9.67M derived: sum of 2 quarters · filed 2018-11-02 | $12.77M 10-Q · filed 2018-11-02 | $13.97M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | $4.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $7.57M 10-Q · filed 2018-08-02 | $8.76M derived: sum of 3 quarters · filed 2019-03-01 | $14.22M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | $3.10M 10-Q · filed 2018-04-27 | $4.29M derived: sum of 2 quarters · filed 2019-03-01 | $9.75M derived: sum of 3 quarters · filed 2019-03-01 | |||||
| 2016-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $6.65M derived: sum of 2 quarters · filed 2019-03-01 | $28.59M 10-K · filed 2019-03-01 | |||||
| 2016-09-30 | $5.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $27.39M 10-Q · filed 2017-11-02 | ||||||
| 2016-06-30 | $21.94M 10-Q · filed 2017-07-28 | |||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $9.22M derived: sum of 2 quarters · filed 2018-02-28 | $13.44M derived: sum of 3 quarters · filed 2018-02-28 | $19.52M 10-K · filed 2018-02-28 | ||||
| 2015-09-30 | $9.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $13.44M derived: sum of 2 quarters · filed 2016-10-28 | $19.52M 10-Q · filed 2016-10-28 | $29.22M derived: sum of 4 quarters · filed 2017-03-08 | ||||
| 2015-06-30 | $4.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $10.30M 10-Q · filed 2016-08-05 | $20.00M derived: sum of 3 quarters · filed 2017-03-08 | $24.09M derived: sum of 4 quarters · filed 2017-03-08 | ||||
| 2015-03-31 | $6.09M 10-Q · filed 2016-04-29 | $15.78M derived: sum of 2 quarters · filed 2017-03-08 | $19.87M derived: sum of 3 quarters · filed 2017-03-08 | |||||
| 2014-12-31 | $9.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $13.79M derived: sum of 2 quarters · filed 2017-03-08 | $41.11M 10-K · filed 2017-03-08 | |||||
| 2014-09-30 | $4.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $31.41M 10-Q · filed 2015-10-30 | ||||||
| 2014-06-30 | $27.32M 10-Q · filed 2015-07-31 | |||||||
| 2013-12-31 | $12.06M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $18.70M derived: sum of 2 quarters · filed 2016-02-29 | $18.69M derived: sum of 3 quarters · filed 2016-02-29 | $21.24M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $6.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $6.64M derived: sum of 2 quarters · filed 2014-10-31 | $9.19M 10-Q · filed 2014-10-31 | $9.88M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-30 | $2.54M 10-Q · filed 2014-07-30 | $3.24M derived: sum of 3 quarters · filed 2015-03-02 | $5.09M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $2.55M 10-Q · filed 2014-04-30 | $3.25M derived: sum of 2 quarters · filed 2015-03-02 | $5.09M derived: sum of 3 quarters · filed 2015-03-02 | $10.29M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $698.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $2.54M derived: sum of 2 quarters · filed 2015-03-02 | $7.74M derived: sum of 3 quarters · filed 2015-03-02 | $9.24M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $7.04M derived: sum of 2 quarters · filed 2013-11-01 | $8.54M 10-Q · filed 2013-11-01 | $8.59M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-06-30 | $5.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $6.69M 10-Q · filed 2013-08-02 | $6.74M derived: sum of 3 quarters · filed 2014-03-11 | $9.32M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-03-31 | $1.50M 10-Q · filed 2013-05-03 | $1.50M 10-Q · filed 2012-05-04 | $1.54M derived: sum of 2 quarters · filed 2014-03-11 | $4.13M derived: sum of 3 quarters · filed 2014-03-11 | $10.86M derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2011-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $2.63M derived: sum of 2 quarters · filed 2014-03-11 | $9.37M derived: sum of 3 quarters · filed 2014-03-11 | $12.65M 10-K · filed 2014-03-11 | $12.65M 10-K · filed 2012-03-12 | |||
| 2011-09-30 | $2.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $9.32M derived: sum of 2 quarters · filed 2012-11-02 | $12.60M 10-Q · filed 2012-11-02 | $12.60M 10-Q · filed 2011-11-04 | $16.46M derived: sum of 4 quarters · filed 2013-03-08 | |||
| 2011-06-30 | $6.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $10.02M 10-Q · filed 2012-08-03 | $10.02M 10-Q · filed 2011-08-05 | $13.88M derived: sum of 3 quarters · filed 2013-03-08 | $17.53M derived: sum of 4 quarters · filed 2013-03-08 | |||
| 2011-03-31 | $3.28M 10-Q · filed 2012-05-04 | $7.14M derived: sum of 2 quarters · filed 2013-03-08 | $10.80M derived: sum of 3 quarters · filed 2013-03-08 | |||||
| 2010-12-31 | $3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $7.52M derived: sum of 2 quarters · filed 2013-03-08 | $11.12M 10-K · filed 2013-03-08 | $11.12M 10-K · filed 2012-03-12 | ||||
| 2010-09-30 | $3.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $7.26M 10-Q · filed 2011-11-04 | ||||||
| 2010-06-30 | $3.61M 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | $8.02M 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |